Application of cytokines/biomarkers in the detection of acute lung injury induced by explosions

doi:10.3877/cma.j.issn.2095-655X.2016.01.006

Abstract

Abstract:

Blast injury is seen with increasing frequency worldwide in military conflicts, civilian settings and terrorist bombing attacks.In fact, lung is known as one of the most critical organs in blast injury, which is considered to be the most representative damage in the explosion.Moreover, acute lung injury and acute respiratory distress syndrome, induced by primary blast lung injury, are the major cause of immediate death.According to the pathological processes of blast lung injury, biomarkers are used in the diagnosis and evaluation of this kind of injury.In this review, we introduced several biomarkers which are the major diagnosis makers for blast lung injury, and it would provide support for the dynamic observation during the development of blast lung injury.

Key words: Blast wave, Lung injury, Biological markers, Evaluation

Kuijun Chen, Jianmin Wang. Application of cytokines/biomarkers in the detection of acute lung injury induced by explosions[J]. Chinese Journal of Diagnostics(Electronic Edition), 2016, 04(01): 19-22.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2016.01.006

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2016/V04/I01/19

References 34

[1]	Belanger HG,Tracy K,Ruth YG, et al.Cognitive sequelae of blast-related versus other mechanisms of brain trauma[J]. J Int Neuropsychol Soc, 2009, 15(1): 1-8.
[2]	Mcdonald JA,Ballard M. Primary Blast Lung Injury[J]. Am J Respir Crit Care Med, 2015, 191(12): 1462-1463.
[3]	Singleton JA,Gibb IE,Bull AM, et al.Primary blast lung injury prevalence and fatal injuries from explosions：insights from postmortem computed tomographic analysis of 121 improvised explosive device fatalities[J]. J Trauma Acute Care Surg, 2013, 75(2 Suppl 2): S269-S274.
[4]	Cereda M,Xin Y,Meeder N, et al.Visualizing the propagation of acute lung injury[J]. Anesthesiology, 2016, 124(1): 121-131.
[5]	Knöferl MW,Liener UC,Seitz DH, et al.Cardiopulmonary, histological and inflammatory alterations after lung contusion in a novel mouse model of blunt chest trauma[J]. Shock, 2003, 19(6): 519-525.
[6]	Nicolas B,Ware LB.Biomarkers in Acute Lung injury-marking forward progress[J]. Critical Care Clinics, 2011, 27(3): 661-683.
[7]	Fiedler U,Augustin HG.Angiopoietins：a link between angiogenesis and inflammation[J]. Trends Immunol, 2006, 27(12): 552-558.
[8]	Jones PF.Not just angiogenesis-wider roles for the angiopoietins[J]. J Pathol, 2003, 201(4): 515-527
[9]	Calfee CS,Gallagher D,Abbott J, et al.Plasma angiopoietin-2 in clinical acute lung injury：prognostic and pathogenetic significance[J]. Crit Care Med, 2012, 40(6): 1731-1737.
[10]	Fogli S,Mogavero S,Egan CG, et al.Pathophysiology and pharmacological targets of VEGF in diabetic macular edema[J]. Pharmacol Res, 2015(103): 149-157.
[11]	Prokosch V,Fink J,Heiduschka P, et al.VEGF, Ang-2 and SRIF associated abnormal postnatal development of the retinal capillary network in the royal college of surgeons rat[J]. Exp Eye Res, 2011, 92(2): 128-137.
[12]	Huang J,Bae JO,Tsai JP, et al.Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade[J]. Int J Oncol, 2009, 34(1): 79-87.
[13]	Thickett DR,Armstrong L,Christie SJ, et al.Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2001, 164(9): 1601-1605.
[14]	Abadie Y,Bregeon F,Papazian L, et al.Decreased VEGF concentration in lung tissue and vascular injury during ARDS[J]. Eur Respir J, 2005, 25(1): 139-146.
[15]	Marianor M,Zaidah AW,Maraina ChC.Von willebrand factor propeptide：A potential disease biomarker not affected by ABO blood groups[J]. Biomark Insights, 2015(10): 75-79.
[16]	殷杰,阮长耿. 血管性血友病因子前导肽的作用及临床价值[J]. 中华血液学杂志, 2015, 36(10): 883-887.
[17]	Ware LB,Conner ER,Matthay MA.Von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury[J]. Crit Care Med, 2001, 29(12): 2325-2331.
[18]	Matthay MA,Zemans RL.The acute respiratory distress syndrome：pathogenesis and treatment[J]. Annu Rev Pathol, 2011, 6(1): 147-163.
[19]	Vanden steen PE,Deroost K,Deckers J, et al.Pathogenesis of malaria-associated acute respiratory distress syndrome[J]. Trends Parasitol, 2013, 29(7): 346-358.
[20]	Beileke S,Claassen H,Wagner W, et al.Expression and localization of lung surfactant proteins in Human Testis[J]. PLoS One, 2015, 10(11): e0143058.
[21]	Wang Y,Voelker DR,Lugogo NL, et al.Surfactant protein A is defective in abrogating inflammation in asthma[J]. Am J Physiol Lung Cell Mol Physiol, 2011, 301(4): L598-606.
[22]	Park HY,Churg A,Wright JL, et al.Club cell protein 16 and disease progression in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 188(12): 1413-1419.
[23]	Kropski JA,Fremont RD,Calfee CS, et al.Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury[J]. Chest, 2009, 135(6): 1440-1447.
[24]	Determann RM,Millo JL,Waddy S, et al.Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia：a retrospective observational study[J]. B Pulm Med, 2009(9): 49.
[25]	Mc Donald Johnston A,Ballard M. Primary Blast Lung Injury[J]. Am J Respir Crit Care Med, 2015, 191(12): 1462-1463.
[26]	Cross LJ,Matthay MA.Biomarkers in acute lung injury：insights into the pathogenesis of acute lung injury[J]. Critical Care Clinics, 2011, 27(2)L355-377.
[27]	Christophe Q,Sylvain MA,Aurélie F, et al.Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(2): L334-L343.
[28]	Yang G,Hamacher J,Gorshkov B, et al.The dual role of TNF in pulmonary edema[J]. J Cardiovasc Dis Res, 2010, 1(1): 29-36.
[29]	Epanchintsev A,Shyamsunder P,Verma RS, et al.IL-6, IL-8, MMP-2, MMP-9 are overexpressed in fanconi anemia cells through a NF-kappaB/TNF-alpha dependent mechanism[J]. Mol Carcinog, 2015, 54(12): 1686-1699.
[30]	侯晓彬,易定华,李廷慧, 等. P38丝裂原活化蛋白激酶和核转录因子κBP65在胸部爆炸伤致急性肺损伤中的作用[J]. 中华急诊医学杂志, 2005, 14(1)26-29.
[31]	Lindsay CD.Novel therapeutic strategies for acute lung injury induced by lung damaging agents：the potential role of growth factors as treatment options[J]. Hum Exp Toxicol, 2011, 30(7): 701-724.
[32]	González-López A,Albaiceta GM.Repair after acute lung injury：molecular mechanisms and therapeutic opportunities[J]. Critical Care, 2012, 16(2): 1-7.
[33]	Ware LB,Bastarache JA,Wang L. Coagulation and fibrinolysis in human acute lung injury-new therapeutic targets? [J]. Keio J Med, 2005, 54(3): 142-149.
[34]	Ashish A,Hanjing Z,Sandra B, et al.Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness：results from two clinical trials[J]. Am J Physiol Lung Cell Mol Physiol, 2012, 303(8): L634-639.

Please choose a citation manager

Content to export